Pavadi Capital’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-25,954
Closed -$5.25M 21
2022
Q4
$5.25M Buy
25,954
+3,307
+15% +$646K 4.95% 13
2022
Q3
$3.98M Sell
22,647
-2,185
-9% -$447K 3.82% 15
2022
Q2
$5M Buy
24,832
+3,956
+19% +$843K 4.53% 9
2022
Q1
$4.73M Sell
20,876
-1,933
-8% -$455K 4.17% 10
2021
Q4
$6.16M Buy
+22,809
New +$5.65M 4.67% 9

Other funds holding LH

Pavadi Capital's LH Position: Q1 2023 in Review

Pavadi Capital sold out of Labcorp (LH) in Q1 2023, closing a stake of 25,954 shares — an estimated $5.25M sold.

Pavadi Capital first reported a position in LH in Q4 2021 and held it in 5 quarters. The position peaked at $6.16M in Q4 2021. 941 funds tracked by Wall St. Rank hold LH as of Q1 2023.

  • Pavadi Capital reported no remaining Labcorp position as of Q1 2023 after selling out during the quarter.
  • Pavadi Capital sold 25,954 Labcorp shares in Q1 2023, an estimated $5.25M.
  • Pavadi Capital first reported a position in Labcorp in Q4 2021 and held it in 5 quarters.
  • Pavadi Capital's Labcorp position peaked at $6.16M in Q4 2021.
  • 941 funds tracked by Wall St. Rank held Labcorp as of Q1 2023.

Based on Pavadi Capital's 13F filing for Q1 2023, filed 15 May 2023.